|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Pfizer Likely To Add Bextra Warning
10/19/2005 5:12:08 PM
Pfizer Inc. is likely to add a so-called "black box" warning to the label of its pain killer Bextra, which is similar to the recently pulled Vioxx, because it sometimes leads to a serious skin reaction. Pfizer made the announcement in its most recent quarterly report, filed with the Securities and Exchange Commission Friday. A black-box warning is the strongest warning available for prescription drugs.
The drug has in a few cases caused Stevens Johnson syndrome, which occurs when the immune system turns on itself to rid itself of a drug, in effect burning the patient from the inside out.
It leads to severe, painful blistering of the mucous membranes and skin, according to Jean Farrell-McCawley, founder of the Stevens Johnson Syndrome Foundation. In many patients, their skin actually starts coming off in sheets, she said.
|
|
|
|
|
|
|
|
|
|
|